Shayan Mostafaei

Shayan Mostafaei

Auto-generated profile, based on publicly available information

Shayan Mostafaei

Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
NKNiloofar Khodabandehlou
Niloofar Khodabandehlou
SMShayan Mostafaei
Shayan Mostafaei
AEAshkan Etemadi
Ashkan Etemadi
AGAmir Ghasemi
Amir Ghasemi
MPMehrdad Payandeh
Mehrdad Payandeh
MMMohsen Moghoofei
Mohsen Moghoofei
Breast cancer is currently the most common neoplasm diagnosed in women globally. There is a growing body of evidence to suggest that human papillomavirus (HPV) infection may play a key role in invasiveness of breast cancer. The aim of this study was to determine the presence of HPV in patients with breast cancer and its possible association with cancer progression. Breast specimens were collected from 72 patients with breast cancer and 31 healthy controls. The presence of HPV was investigated by polymerase chain reaction (PCR) and genotyping was performed for positive cases. We also evaluated the viral factors such as E6, E2, and E7 in HPV positive cases. Enzyme-linked immunosorbent assay (ELISA (and Real-time PCR techniques were used to measure the expression level of anti-carcinogenic genes, such as p53, retinoblastoma (RB), breast and ovarian cancer susceptibility gene (BRCA1, BRCA2) and inflammatory cytokines, including tumor necrosis factor α (TNF-α), transforming growth factor β (TGF-β), nuclear factor-kB (NF-kB), and different interleukins [ILs] (IL-1,IL6, and IL-17). The HPV DNA was detected in 48.6% of breast cancer samples, whereas only 16.1% of controls were positive for HPV. We observed statistically significant differences between breast cancer patients and HPV presence (P = 0.003). HPV type 18 was the most prevalent virus genotype in patients. The expression of P53, RB, BRCA1, and BRCA2 were decreased in patients with HPV-positive breast cancer as compared to HPV-negative breast cancer and healthy controls. (All P-values were less than 0.05). The presence of the HPV was associated with increased inflammatory cytokines (IL-1, IL-6, IL-17, TGF-β, TNF-α, and NF-kB) and tumor progression. The present study demonstrated that HPV infection may implicate in the development of some types of breast cancer.

1 August 2017 in Microbial Pathogenesis
Verified
Journal Article
Closed access
RMReza Mirnejad
Reza Mirnejad
FJFaramarz Masjedian Jazi
Faramarz Masjedian Jazi
SMShayan Mostafaei
Shayan Mostafaei
MSMansour Sedighi
Mansour Sedighi

24 September 2019 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
SMShayan Mostafaei
Shayan Mostafaei
HAHamid Abdollahi
Hamid Abdollahi
SDShiva Kazempour Dehkordi
Shiva Kazempour Dehkordi
ISIsaac Shiri
Isaac Shiri
ARAbolfazl Razzaghdoust
Abolfazl Razzaghdoust
SMSeied Rabi Mahdavi
Seied Rabi Mahdavi

1 March 2020 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
KBKamran Baveicy
Kamran Baveicy
SMShayan Mostafaei
Shayan Mostafaei
MDMitra Darbandi
Mitra Darbandi
BHBehrooz Hamzeh
Behrooz Hamzeh
FNFarid Najafi
Farid Najafi
YPYahya Pasdar
Yahya Pasdar
Background: The use of anthropometric indices is one of the new and low-cost diagnostic methods of metabolic syndrome (MetS). The present study aimed to determine optimal cutoff points for the visceral adiposity index (VAI), body roundness index (BRI), and a body shape index (ABSI) in the prediction of MetS. Methods: This cross-sectional study was performed on 10,000 individuals aged from 35 to 65 years, recruited in Ravansar Non-Communicable Diseases (RaNCD) cohort study, in the west region of Iran, in 2019. MetS was defined according to International Diabetes Federation (IDF) criteria. The receiver operating characteristic (ROC) curve analysis was used to assess predictive anthropometric indices and determine optimal cutoff values. Results: The optimal cutoff points for VAI were 4.11 (AUC: 0.82; 95% CI: 0.81– 0.84) in men and 4.28 (AUC: 0.86; 95% CI: 0.85– 0.87) in women to prediction of MetS. The optimal cutoff points for BRI were 4.75 (AUC: 0.75; 95% CI: 0.74– 0.77) in men and 6.17 (AUC: 0.62; 95% CI: 0.61– 0.64) in women to prediction of MetS. The optimal cutoff points for ABSI were 0.12 (AUC: 0.49; 95% CI: 0.47– 0.51) in men and 0.13 (AUC: 0.49; 95% CI: 0.47– 0.51) in women to prediction of MetS. The risk of MetS in men and women with a VAI higher than the optimal cutoff point was, respectively, 9.82 and 11.44 times higher than that in those with a VAI lower than the cutoff point. Conclusion: Although VAI might not be very cost-beneficial compared to IDF, our study showed VAI is a better predictor of MetS than BRI in adults. ABSI was not a suitable predictor for MetS.

1 April 2017 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
MMmohammad hossein Mohammadi
mohammad hossein Mohammadi
BMBehnam Molavi
Behnam Molavi
SMSaeed Mohammadi
Saeed Mohammadi
MNMohsen Nikbakht
Mohsen Nikbakht
AMAshraf Malek Mohammadi
Ashraf Malek Mohammadi
AGArdeshir Ghavamzadeh
Ardeshir Ghavamzadeh

1 December 2017 in Microbial Pathogenesis
Verified
Journal Article
Closed access
HJHabib Jafarinejad
Habib Jafarinejad
MMMohsen Moghoofei
Mohsen Moghoofei
SMShayan Mostafaei
Shayan Mostafaei
JSJafar Salimian
Jafar Salimian
SAsadegh azimzadeh
sadegh azimzadeh
AAAli Ahmadi
Ali Ahmadi